| Original language | English (US) |
|---|---|
| Pages (from-to) | 1429-1430 |
| Number of pages | 2 |
| Journal | Clinical Infectious Diseases |
| Volume | 65 |
| Issue number | 8 |
| DOIs | |
| State | Published - Oct 1 2017 |
Funding
ports receiving personal fees from UpToDate, Elsevier, the American College of Physicians, and Merck, outside the submitted work. R. H. reports receiving personal fees from Biomerieux, The Medicines Company, Pfizer, Biofire, and Merck, outside the submitted work. S. L. K. reports receiving institutional grant support from Pfizer, Forest Laboratories, and Merck/Cubist, outside the submitted work. W. M. S. reports receiving grants from the National Institutes of Health, Pfizer, and Wyeth, outside the submitted work. D. v. d. B. reports receiving grants from the Netherlands Organization for Health Research and Development, the Netherlands Scientific Organization, the European Research Council, FP-7, Horizon 2020, and Omeros, and other support from GlaxoSmithKline, outside the submitted work. T. P. B. reports receiving grant support from Zoll, Sage, and Edge, outside the submitted work. All other authors report no potential conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases